CD99 Immunoreactivity in Atypical Fibroxanthoma
Open Access
- 1 January 2002
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 117 (1), 126-131
- https://doi.org/10.1309/2exb-70cw-3u6p-vq6h
Abstract
Atypical fibroxanthoma (AFX), a pleomorphic superficial cutaneous tumor of low-grade malignancy, shares many morphologic features with malignant melaKeywords
This publication has 22 references indexed in Scilit:
- Giant Cell Atypical Fibroxanthoma: Does it Really Exist?The American Journal of Dermatopathology, 1999
- Synovial sarcomaAnnals of Diagnostic Pathology, 1998
- Cellular ‘neurothekeoma’: an epithelioid variant of dermatofibroma?Histopathology, 1998
- Immunohistochemical Profile of Monoclonal Antibody 013The American Journal of Surgical Pathology, 1994
- The spectrum of fibrohistiocytic tumours with special emphasis on malignant fibrous histiocytomaCurrent Diagnostic Pathology, 1994
- Atypical FibroxanthomaThe American Journal of Surgical Pathology, 1993
- Cellular Neurothekeoma A Distinctive Variant of Neurothekeoma Mimicking Nevomelanocytic TumorsThe American Journal of Surgical Pathology, 1990
- Immunostaining in Atypical Fibroxanthoma of the SkinPathology - Research and Practice, 1988
- Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.Journal of Clinical Pathology, 1984
- Leiomyosarcoma of the skin and subcutaneous tissueCancer, 1981